Med1

The scope of this expert panel includes basic, translational and preclinical research on pharmaceutical sciences and medical biochemistry in humans and animals.

Innovative intervention studies (including medical devices, technologies and tools for prevention, diagnosis and treatment of human and animal diseases) are eligible only if they address a fundamental scientific question.

In particular, the following topics are covered (not exhaustive):

• In vivo and in vitro pharmacology (human and animal) of small molecules & biopharmaceuticals, pharmacokinetics (drug ADME), pharmacodynamics (effects on biological systems), analysis and synthesis of pharmaceutical compounds. It further covers molecular and cellular mechanisms, cellular communication, including cell signaling & signal transduction, ion channels & transport proteins
• In vivo and in vitro toxicology of small molecules & biopharmaceuticals and covers as well toxicokinetics as toxicodynamics; it includes analytical, pharmaceutical, forensic and systems toxicology, food toxicology
• Pharmaceutical (bio)technology, drug discovery and drug development technology, drug delivery and drug disposition (including medicinal plants and natural products).
• Bromatology, medicinal chemistry, enzymology, pharmaceutical material technology, radiopharmacy, pharmacognosy
• Structural and functional research of human proteins, covering their role in cellular basic processes and including proteome analyses (functional and spatial proteomics)
• Biochemical and metabolic research, including proteins/nucleic acids/lipid/carbohydrate metabolism, biomarker technology (detection), animal free laboratory research, including development of New Approach Methodology (NAM)
• Target identification & validation
• Medical biochemistry